BioHealth News Archive
Head of JLABS @ Washington, D.C., Sally Allain, MSc., MBA, Guests on BioTalk
Sally Allain, MSc., MBA, Head of JLABS @ Washington, D.C. joins Rich Bendis on BioTalk to discuss her career, the decision to open a…
Read MoreJ&J, BARDA pick 7 startups to back in fight against COVID-19—and beyond | FierceBiotech
As the world scrambles to develop diagnostics, treatments and vaccines for COVID-19, one big question looms: How will we face the next pandemic? Johnson…
Read MoreGSK is hiring in Richmond.
Microbiology Team Leader - https://jobs.gsk.com/en-gb/jobs/241125?lang=it-it (we also have a video of the line manager talking about the role, if you can add it to the newsletter) New Product…
Read MoreVaccitech Awarded U.K. Grant for COVID Vaccine Research
Vaccitech officials say the company received a U.K. government grant to support research with its next-generation technology platform to protect against COVID-19. The grant…
Read MoreAlexandria Venture Investments Recognized as #1 Most Active Biopharma Investor for Third Consecutive Year
PASADENA, Calif., Sept. 4, 2020 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban…
Read MoreSanofi, GSK start human trial of their COVID-19 vaccine
Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a clinical trial for their jointly developed COVID-19 vaccine candidate. A total of…
Read MoreSkincare of the Future QuickFire Challenge – Challenge | JLABS
Advances in science and technology can drive the next generation of skincare innovations. Today, cutting edge dermatological research and technologies hold the potential to revolutionize pore minimizing and anti-aging solutions. To that end, Johnson &…
Read MoreNobelpharma Press Release — MCEDC
ROCKVILLE, Md. — Recognizing the benefits of proximity to leading U.S. researchers, regulators and advocacy groups, Nobelpharma America, LLC has chosen Montgomery County, Maryland…
Read MoreTruGenomix, a Veteran-Led Biotech Instrumental in Early Identification & Awareness of PTSD, Raises $1.8 Million Seed Round, Led by Sanford Health & Viking Global
TruGenomix recently announced $1.8 million in financing in a seed round led by Sanford Health. The startup, a graduate of the Illumina Accelerator program…
Read MoreBiotech leaders call for Covid-19 data transparency, FDA independence
WASHINGTON — A group of prominent biotech CEOs are calling on their peers and the federal government to hold themselves to the highest standards…
Read MoreCeres Nanosciences Receives $6.5M NIH Award
MANASSAS, Va. — September 2, 2020 — Ceres Nanosciences, a privately held company that makes innovative products to improve diagnostic testing, announced it has been…
Read MoreNIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test
CHARLOTTESVILLE, Va., Sept. 2, 2020 /PRNewswire/ -- MicroGEM today announced it has been awarded up to $40.9 million by the National Institutes of Health (NIH),…
Read MoreAstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine
AstraZeneca said today it has launched a 30,000-patient Phase III trial in the U.S. of AZD1222, the COVID-19 vaccine it is co-developing with the…
Read MoreCalifornia developer Alexandria Real Estate proposes office, lab building at Baltimore’s Port Covington – Baltimore Business Journal
The 170,000-square-foot building would be located near Rye Street Tavern. {iframe}https://www.bizjournals.com/baltimore/news/2020/09/01/alexandria-proposes-port-covington-building.html{/iframe}
Read MoreJohnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration – News | JLABS
WASHINGTON, D.C., August 27, 2020 - Johnson & Johnson Innovation LLC today announced the first companies to be part of its medical countermeasure innovation…
Read More